Translating Regenerative Medicine Science into Clinical Practice: the Local to Global pivot

In by

Spotlight Article

Expert Insight

SUPPLY CHAIN MANAGEMENT PART 2: CREATING A LOGISTICS STRATEGY FOR COMMERCIALIZATION

Richard P Harrison, Aileen Gracias and William Mitchell

Research into cell and gene therapies is globally dispersed, which creates scientific opportunities, but in turn, significant commercial challenges. In order to successfully bring promising scientific endeavors through to commercial opportunity, greater cross-border coordination of supply side activity considerations such as academic institutions, funding gaps, intellectual property, and commercial entities as well as demand-side issues of reimbursement, regulatory policy, stakeholder engagement and patient engagement should be advocated for.

Submitted for peer review: April 12 2018 Published: July 9 2018
DOI:10.18609/cgti.2018.043
Citation: Cell Gene Therapy Insights 2018; 4(5), 469-483.
Open access

This content is restricted to registered users. Click here to Register or Login here.